跳至主要内容
临床试验/NCT02675582
NCT02675582已完成不适用

Investigation of the Acute Calming Effects of Drinks Containing Herbal Extracts in Healthy Adults

PepsiCo Global R&D1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
1
主要终点
Change in mood

研究概览

简要总结

The primary objectives of this study are to assess the effects of three investigational drinks containing three botanicals in differing combinations versus a placebo control, on mood, psychological state, physical response, and cognitive performance during and after exposure to an observed multi-tasking stressor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Aged 18 to 49 years
  • •Self-report of good health
  • •Are not excluded on the basis of the following

排除标准

  • •Exclusion Criteria:
  • •Are a smoker
  • •Have food allergies or sensitivities to any of the ingredients contained in the investigational product or any other foodstuff
  • •Currently take medication except the contraceptive pill
  • •Have habitually used dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total)
  • •Have sleep disturbances and/or are taking sleep aid medication Are employed in a job that includes night shift work
  • •Have a Body Mass Index (BMI) outside of the range 18-35 kg/m2or weigh less than 50kg or more than 85kg.
  • •Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg)
  • •Have a history of neurological, vascular or psychiatric illness including epilepsy or seizures (excluding depressive illness and anxiety)
  • •Have a history of anxiety or a current diagnosis of anxiety or depression
  • •Are pregnant, trying to get pregnant or breast feeding
  • •Have a recent history of (within 12 months of screening visit) or strong potential for alcohol or substance abuse. Alcohol abuse is defined as more than 60g (men) / 40g (women) pure alcohol per day (7 / 5.5 units)
  • •Have learning difficulties or dyslexia
  • •Have visual impairment that cannot be corrected with glasses or contact lenses
  • •Have frequent migraines that require medication (more than or equal to 1 per month)
  • •Have disorders of the blood (e.g. anaemia, hemophilia, thrombocytosis)
  • •Have a heart disorder or a history of vascular illness
  • •Have a respiratory disorder that requires regular medication (Note: participants with asthma who only take their medication occasionally/as required are eligible for this study)
  • •Have a diagnosis of type I or type II diabetes
  • •Have a history of renal or hepatic disease, or other severe diseases of the gastrointestinal tract (e.g. iron accumulation, iron utilization disorders, hypercalcaemia, hypercalciuria), that are likely to interfere with metabolism/absorption/secretion of the product under investigation
  • •Have any health condition that would prevent fulfillment of the study requirements
  • •Are currently or have in the past 8weeks participated in other clinical or nutrition intervention studies
  • •Have participated in the BPNRC's recent stress study
  • •Do not have a bank account (required for payment)

研究组 & 干预措施

Control

Placebo Comparator

Mix 1 flavored still beverage

干预措施: Herbal Beverage (Other)

Herbal beverage 1

Experimental

Mix 2 flavored still beverage with a botanical extract(1)

干预措施: Herbal Beverage (Other)

Herbal Beverage 2

Experimental

Mix 3 flavored still beverage with a botanical extract(2)

干预措施: Herbal Beverage (Other)

Combined Herbal Beverage

Experimental

Mix 4 flavored still beverage with 2 botanical extracts (1,2)

干预措施: Herbal Beverage (Other)

结局指标

主要结局

Change in mood

时间窗: Pre dose, 60, 150, 240 min post dose

During each assessment mood and psychological state will be assessed before and after performance of an observed multi-tasking stressor via completion of the 'State' subscale of the State-Trait Anxiety Inventory and computerised versions of the Bond-Lader visual analogue mood scales and separate visual analogue scales (VAS) measuring subjective stress, relaxation and calmness.

次要结局

  • Change in Cognitive function(Pre dose, 60, 150, 240 min post dose)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验